Algiamed Technologies USA, Inc.
Explore this company’s associated devices, FDA decisions and regulatory history.

Algiamed Technologies USA, Inc.
- Regulatory records
- 1
- Linked recall entries
- 0
- Headquarters
- Not reported
- Brand website
- Not reported
What the linked records show
MedtechLedger currently links 1 FDA record to the applicant name Algiamed Technologies USA, Inc.. The collection includes 1 510(k) clearance. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from May 28, 2026 to May 28, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code GZJ appears in 1 of the 1 linked filings. The collection spans 1 FDA product code. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
Applicant mailing address recorded by FDA: 801 International Pkwy. 5th Floor, Lake Mary, FL, 32746, US. Recorded on K252712, decision dated May 28, 2026.
Device categories in this collection
Stimulator, Nerve, Transcutaneous, For Pain Relief.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
Devices & associated records
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Algiamed Technologies USA, Inc. | 510(k) clearance | May 28, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.
